These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7974630)

  • 1. Comparison of gentamicin pharmacokinetic parameters determined by fluorescence polarization immunoassay and latex agglutination methods.
    Madaras-Kelly KJ; Mihalovic S; Zittel D; Ehresman D; Lakatua DJ; Rotschafer JC
    Ther Drug Monit; 1994 Aug; 16(4):395-9. PubMed ID: 7974630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observed differences in gentamicin pharmacokinetic parameters and dosage recommendations determined by fluorescent polarization immunoassay and radioimmunoassay methods.
    Rotschafer JC; Berg HG; Nelson RB; Strand L; Lakatua DJ
    Ther Drug Monit; 1983; 5(4):443-7. PubMed ID: 6362098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radioimmunoassay and enzyme immunoassay methods in determining gentamicin pharmacokinetic parameters and dosages.
    Rotschafer JC; Morlock C; Strand L; Crossley K
    Antimicrob Agents Chemother; 1982 Oct; 22(4):648-51. PubMed ID: 6758688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observed differences in amikacin pharmacokinetic parameters and dosage recommendations determined by enzyme immunoassay and fluorescence polarization immunoassay.
    Bleske BE; Larson TA; Rotschafer JC
    Ther Drug Monit; 1987; 9(1):48-52. PubMed ID: 3554628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of fluorescence polarization immunoassay and microbiological assay in the study of gentamicin pharmacokinetics in man and a comparison of the results].
    Cai WM; Chen G
    Yao Xue Xue Bao; 1990; 25(2):81-4. PubMed ID: 2239326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gentamicin immunoassays using univariate and multivariate analyses.
    Boyce EG; Lawson LA; Gibson GA; Nachamkin I
    Ther Drug Monit; 1989; 11(1):97-104. PubMed ID: 2643207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery.
    Tudor RA; Papich MG; Redding WR
    J Am Vet Med Assoc; 1999 Aug; 215(4):503-6. PubMed ID: 10461634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
    White LO; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation.
    Santschi EM; Papich MG
    J Vet Pharmacol Ther; 2000 Dec; 23(6):359-63. PubMed ID: 11168913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the fluorescence polarization immunoassay and the microbiological assay methods for the determination of gentamicin concentration in human serum.
    Tayeb OS; el-Tahawy AT; Islam SI
    Ther Drug Monit; 1986; 8(2):232-5. PubMed ID: 3726941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle concentration fluorescence immunoassay of gentamicin.
    Varma-Nelson P; Nelson JE; Belknap SM
    Ther Drug Monit; 1991 May; 13(3):260-2. PubMed ID: 1926282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of enzyme-multiplied immunoassay technique with fluorescence polarization immunoassay for determination of gentamicin and tobramycin levels in serum.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Clin Microbiol; 1984 Nov; 20(5):866-8. PubMed ID: 6392321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
    Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
    Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial dosage regimens of gentamicin in patients with burns.
    Zaske DE; Chin T; Kohls PR; Solem LD; Strate RG
    J Burn Care Rehabil; 1991; 12(1):46-50. PubMed ID: 2022681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometry method for quantification of gentamicin and its individual congeners in serum and comparison results with two immunoanalytical methods (fluorescence polarization immunoassay and chemiluminiscent microparticle immunoassay).
    Brozmanova H; Urinovska R; Safarcik K; Vsiansky F; Kacirova I; Grundmann M
    Clin Chim Acta; 2021 Oct; 521():191-198. PubMed ID: 34274343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
    Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
    Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.